Welcome to our dedicated page for Camtek SEC filings (Ticker: CAMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Camtek Ltd (CAMT) SEC filings page on Stock Titan aggregates the company’s U.S. regulatory disclosures as a foreign private issuer. Camtek files an Annual Report on Form 20-F and furnishes interim information on Form 6-K, including press releases, unaudited financial statements, and operating and financial review documents. These filings provide detailed insight into its business as a developer and manufacturer of high-end inspection and metrology equipment for the semiconductor industry.
Through recent Form 6-K reports, investors can review Camtek’s quarterly and year-to-date financial results, including GAAP and non-GAAP figures, segment commentary, and management discussion of drivers such as advanced packaging, Memory and HBM, and high-performance computing for AI applications. The company also explains its use of non-GAAP measures that exclude share-based compensation, acquisition-related expenses, and, in some periods, expenses related to the extinguishment of convertible notes.
Filings further document Camtek’s capital structure activity. A Form 6-K dated September 16, 2025, describes the closing of an aggregate $500 million principal amount of 0.00% Convertible Senior Notes due 2030, issued under an indenture and positioned as senior unsecured obligations. The filing outlines key terms such as maturity, conversion mechanics, redemption and repurchase provisions, and the intended use of proceeds, including repurchase of existing 0% convertible notes due 2026 and general corporate purposes.
On Stock Titan, these SEC documents are paired with AI-powered tools that help readers navigate complex items such as Form 6-K exhibits, indenture summaries, and reconciliations between GAAP and non-GAAP performance. Users can quickly locate quarterly results, capital markets transactions, and risk factor discussions that Camtek references in its filings without reading every line of each report.
Camtek Ltd. has signed a definitive agreement to acquire Visual Layer, a Tel Aviv-based AI company specializing in visual analytics, to strengthen its AI-driven inspection and metrology solutions for the semiconductor industry. Visual Layer contributes proprietary visual AI technology and an experienced research and engineering team.
Camtek’s leadership describes AI as a strategic priority and expects the deal to accelerate product development, improve system throughput and performance, and support potential AI-based software and analytics offerings that could become an additional recurring revenue stream over time. The companies have already collaborated for over a year, integrating Visual Layer’s technology into Camtek’s systems.
The transaction is subject to customary closing conditions and is expected to close in the next few weeks, with further details to be provided alongside Camtek’s first quarter 2026 results, anticipated in May 2026.
Camtek Ltd. Chief Executive Officer Amit Rafi filed a Form 3 as an officer of the company, reporting direct holdings of ordinary shares and multiple equity awards in the form of restricted stock units (RSUs) and performance stock units.
Some of the reported ordinary shares were issued upon vesting of previously granted performance or restricted stock units. The footnotes describe several RSU grants that each represent a contingent right to receive one ordinary share, with vesting schedules that start in 2024 and extend through 2027, based on continued service and using a mix of annual and quarterly vesting.
Camtek Ltd. director Orit Stav filed an initial statement of beneficial ownership, outlining current holdings in ordinary shares and stock options. The filing shows direct ownership of ordinary shares and several option grants over Camtek ordinary shares with different exercise prices and maturities.
Fully vested and immediately exercisable stock options cover 3,176 ordinary shares at an exercise price of $22.6300 per share, alongside additional option grants over 880 shares at $63.5100, 1,132 shares at $81.2800, and 1,095 shares at $59.7600 per share, each with stated expiration dates through 2032. The filing also notes restricted stock units that convert into ordinary shares, with certain RSUs and options scheduled to vest on the date of Camtek’s 2026 annual meeting of shareholders, subject to continued service.
Camtek Ltd Vice President of HR Orit Geva‑Dvash has filed an initial Form 3 reporting direct ownership of several blocks of ordinary shares of Camtek Ltd. Each entry lists ordinary shares held directly, establishing her baseline equity position as an officer of the company.
Footnotes explain that some of these ordinary shares were issued upon vesting of previously granted restricted stock units (RSUs), each RSU representing a contingent right to receive one ordinary share. Additional RSU grants are scheduled to vest over time, with structures that include 25% vesting on an initial vesting date followed by the remaining 75% in twelve equal quarterly installments, or in four equal annual installments of 25% per year, with specific first vesting dates on 01/16/2024, 02/15/2024, 04/01/2025, 03/18/2026, and 03/30/2027, all subject to her continued service.
CAMTEK LTD director Yotam Stern filed an initial Form 3, which is a statement of beneficial ownership for insiders. This filing lists him as a director of the company and reports no stock transactions or derivative positions in this submission.
CAMTEK LTD director Yosef Shacham filed an initial Form 3 detailing his existing equity stake in the company. The filing lists several stock options to buy ordinary shares, including 1,426 shares at an exercise price of $36.45 expiring on 2028-08-18 and 3,176 shares at $22.63 expiring on 2029-11-10. It also shows options for 880 shares at $63.51, 1,132 shares at $81.28 and 1,095 shares at $59.76 with expirations from 2030 to 2032. In addition, he holds 5,852 and 628 ordinary shares, some issued upon vesting of restricted stock units, with certain RSUs and options vesting at the company’s 2026 annual meeting of shareholders subject to continued service.
Camtek Ltd director Ben Arie Mordechay filed an initial ownership report showing his equity position in the company. The filing lists fully vested stock options over 880 ordinary shares at an exercise price of $63.51, 1,509 shares at $81.28, and 1,095 shares at $59.76, with expirations between 2030 and 2032. It also shows direct holdings of ordinary shares, including 1,009 shares and 628 shares. Footnotes explain that some shares were issued upon vesting of restricted stock units and that certain options and RSUs will vest on the date of Camtek’s 2026 annual meeting of shareholders, subject to continued service.
Camtek Ltd. director Andorn Karni Yarl filed an initial ownership report showing existing holdings of ordinary shares and stock options. The filing lists 1,937 and 628 ordinary shares held directly, plus multiple stock option grants over ordinary shares with exercise prices between $22.63 and $81.28. Footnotes state some ordinary shares were issued upon vesting of previously granted RSUs and note that certain RSUs and options will vest on the date of the Company’s 2026 annual meeting of shareholders, subject to continued service.
Camtek Ltd’s Chief Financial Officer, Moshe Eisenberg, filed an initial ownership report showing direct holdings of ordinary shares and multiple grants of restricted stock units (RSUs). Each RSU represents a contingent right to receive one ordinary share of the company.
The RSUs vest over several years, typically with 25% vesting on a first vesting date and the remaining 75% vesting in equal quarterly or annual installments, subject to continued service. First vesting dates disclosed include 01/16/2024, 02/15/2024, 04/01/2025, 03/18/2026, and 03/30/2027, outlining a long-term equity compensation schedule for the CFO.
Camtek Ltd Chief Operating Officer Ram Langer filed an initial Form 3 reporting his beneficial ownership of the company’s ordinary shares. The filing lists several direct holdings of ordinary shares and explains that many of these shares were or will be issued upon vesting of performance stock units and restricted stock units. These equity awards generally convert into one ordinary share each and vest over multi‑year schedules, with initial vesting dates beginning on 01/16/2024 and additional installments continuing annually or quarterly through 03/30/2027, contingent on Mr. Langer’s continued service.